What's wrong w/ this ECNM
Can this be cleared?
Should and what do you ask the EA?
100

Matter Name:

Bone-directed therapeutics for the treatment of cancer

Matter title should be updated to: Bone-Directed Therapeutics for the Treatment of Cancer

100

Matter is marked HC

AOP - 501 Technology Transaction

Matter Title: Project Apex

Parties: none

No, this should be sent to CA for clearance

100

C/M title:  Enumerix, Inc. / Non-Invasive Prenatal Testing Landscape Review

C/M # 56396.007


Yes, verify with EA and working patent team member for a patent matter number 

200

What is missing?

Admin Contact Member: Randy Lewis

Conflicts Attorney:

Pre-bill Attorney:

Filekeeper: Kibibi Shaw

Admin Contact Member: Randy Lewis

Conflicts Attorney: Randy Lewis

Pre-bill Attorney:

Filekeeper: Kibibi Shaw

200

Matter Title : Methods for Treating Wounds Using Belite Bio 

AOP: 504

Parties: none

No, Belite Bio is likely a party that should be added, confirm with EA first before processing


200

Matter Title: Revela, Inc. // Due Diligence

AOP: 504

Yes, ask if AOP can be changed to 505 - Patent Advice as due diligence matters fall under this category 

300

Points Allocation:

Lowell Segal: 150

SOMA Group: 50

Individuals should not have over 100 points, only groups may have over 100, EA should be contacted.

300

Matter Title: SAGA-Associated Factor 29 IP Review and Diligence

AOP: 505

Parties: none

No, IP Review matter titles require confirmation with EA's to ensure parties are not missed as this type of matter title refers to:

  • Due Diligence of a patent portfolio is an audit of the IP assets owned by or licensed to a company/individual to assess its value. Diligence is typically done prior to finalizing any licensing, financing, investment, public offering, or M&A transactions.
300

Matter Title: 10X Genomics, Inc. // Protease Treatment Method for Preparing Biological Samples

Matter comments: 01/23/2023 ECNM #135459 submitted by S. Whitaker-Pacquiet. EL = MB. Not Pro Bono or HC/PHC, no bad debt. Phan

No, but follow up with patent records team is important here as they need to patent approve the matter prior to us continuing

400

Client: Arch Ventures

AOP: 131 - Private Financing Equity

Matter Tittle: Series Seed Financing Investment 

Role/Relationship: Belite Bio (Adverse/Investor)

Corrections:

AOP: 203 - Venture Counsel

Matter Tittle: Belite Bio Series Seed Investment

Role/Relationship: Belite Bio (Adverse/Issuer)

400

Matter Name: Series Seed Investment

Client Name: Sand Hill Angels

AOP : 131

Party: none

EL: Blank

No, AOP should be changed to 203 and engagement letter status is blank we need a CA to clear

400

Matter Name: ToolGen Inc. // Interference No. 106,126

C/M #63474.650

Yes, confirm with EA and patent working team if we should continue with litigation number or if a patent number should be used instead

500

Matter Title: Prosecution Strategy

Parties: none

AOP: 504

Nothing is wrong, ok to clear

500

Matter Title: General Corporate Matters

Matter Reactivation: Yes

Parties: no

AOP: 101


No, we must rerun and send as a matter reactivation for clearance and verify with EA if points and parties remain the same (if any parties were ever listed)

500

Matter Title: GC Therapeutics, Inc. // Cambridge EP Patent Analysis

Parties: none

Yes, ask EA if Cambridge is a party in the matter if so what the full legal name is and send matter for clearance

M
e
n
u